학술논문
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells
Document Type
redif-article
Author
Source
Nature, Nature. 494(7435):100-104
Subject
Language
English
Abstract
Immune rejection may limit the therapeutic use of induced pluripotent stem cells (iPSCs); here, terminally differentiated mouse iPSCs are shown to generate negligible immune rejection in their host.